Strs Ohio cut its stake in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Rating) by 41.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,400 shares of the biotechnology company’s stock after selling 3,900 shares during the quarter. […]